The Week Ahead: BP, Glaxo, Barratt, Royal Mail, BAT
4th February 2022 12:49
by Richard Hunter from interactive investor
Share on
It's a busy week for FTSE 100 results as some of the most popular stocks update on trading. These are the big names to watch for this side of the pond. US results season is also in full swing and producing plenty of spectacular headlines.
- Your vote counts: ex-RBS chief to host first easyJet AGM
- No trading fees on US shares until 11 February. Click here for details
- Find out which US companies report results in the days and weeks ahead
- Meta’s share crash wipes $200 billion off valuation
- UK stock market outlook 2022: reasons to be cheerful, despite rate risks
- Friends & Family: ii customers can give up to 5 people a free subscription to ii, for just £5 a month extra. Learn more
Monday 7 February
Trading statements
K3 Capital, Lamprell, Lok'nStore, Brown Advisory US Smaller Cos
AGM/EGM
Minds + Machines Group
Tuesday 8 February
Trading statements
Alumasc, Bellway, BP (LSE:BP.), DCC, Mattioli Woods, Micro Focus, Ocado Group (LSE:OCDO), SSE
AGM/EGM
Barkby Group, Numis Corp
Wednesday 9 February
Trading statements
Barratt Developments (LSE:BDEV), Discoverie, Dunelm, GlaxoSmithKline (LSE:GSK), Grainger, PZ Cussons, Smurfit Kappa
AGM/EGM
Contango Holdings, Euromoney Institutional Investor, Finsbury Growth & Income Trust, Grainger, JPMorgan Asia Growth & Income, Oxford Metrics, Petra Diamonds, Schroder UK Mid Cap Fund
Thursday 10 December
Companies scheduled to begin trading without the right to the latest dividend include Virgin Money UK (LSE:VMUK) and Impax Asset Management Group (LSE:IPX).
Trading statements
Aferian, Ashmore Group, AstraZeneca (LSE:AZN), Beazley, Feedback, MJ Gleeson, Redrow, RELX, Royal Mail (LSE:RMG), S&U, Tate & Lyle, Unilever (LSE:ULVR), Watches of Switzerland
AGM/EGM
Benchmark Holdings, BMO Capital & Income Investment Trust, easyJet, Foxtons, SEC Newgate, Tritax EuroBox
Friday 11 February
Trading statements
British American Tobacco (LSE:BATS), Tate & Lyle
AGM/EGM
Victrex, Mineral & Financial Investments, Polar Capital Global Healthcare Trust
These articles are provided for information purposes only. Â Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties. Â The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.
Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.